Paper · 36769694
Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases.
Lahlou G and 4 others. J Clin Med, 2023. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases. Papers, record 36769694. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36769694
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ANR-18-RHUS-0007 | Agence Nationale de la Recherche | PubMed | ||
| FPA IDA08 | Fondation pour l'Audition | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References140
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,610,400 | Cochlear transduction via cerebrospinal fluid delivery of AAV in non-human primates. | Mol Ther | 2023 | https://conductscience.org/library/papers/36610400 | PubMed |
| 2 | 34,910,522 | Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss. | Sci Adv | 2021 | https://conductscience.org/library/papers/34910522 | PubMed |
| 3 | 23,587,925 | Mouse otocyst transuterine gene transfer restores hearing in mice with connexin 30 deletion-associated hearing loss. | Mol Ther | 2013 | https://conductscience.org/library/papers/23587925 | PubMed |
| 4 | 24,191,945 | Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. | Hum Gene Ther | 2014 | https://conductscience.org/library/papers/24191945 | PubMed |
| 5 | 23,640,742 | Persistent stapedial arteries in human: from phylogeny to surgical consequences. | Surg Radiol Anat | 2013 | https://conductscience.org/library/papers/23640742 | PubMed |
| 6 | 25,807,962 | Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective. | Hum Gene Ther | 2015 | https://conductscience.org/library/papers/25807962 | PubMed |
| 7 | 27,606,440 | Applications of CRISPR technologies in research and beyond. | Nat Biotechnol | 2016 | https://conductscience.org/library/papers/27606440 | PubMed |
| 8 | 29,315,675 | Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy. | Med Res Rev | 2018 | https://conductscience.org/library/papers/29315675 | PubMed |
| 9 | 36,639,728 | Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing. | Nat Commun | 2023 | https://conductscience.org/library/papers/36639728 | PubMed |
| 10 | 27,074,241 | Advances in fetal surgery. | Einstein (Sao Paulo) | 2016 | https://conductscience.org/library/papers/27074241 | PubMed |
1 to 10 of 140
See all 140 referencesCited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,649,271 | Mapping the global trends and hotspots of research on gene therapy and hair cell regeneration for hearing loss: a comprehensive data-mining-based study. | Gene Ther | 2026 | https://conductscience.org/library/papers/42649271 | PubMed |
| 42,346,617 | Genomic and Epigenomic Advances in Hearing Loss: Molecular Mechanisms, Diagnostics, and Emerging Therapies. | J Pers Med | 2026 | https://conductscience.org/library/papers/42346617 | PubMed |
| 42,318,138 | Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42318138 | PubMed |
| 42,137,272 | Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42137272 | PubMed |
| 40,791,787 | Optical method to preserve residual hearing in patients receiving a cochlear implant. | Front Audiol Otol | 2024 | https://conductscience.org/library/papers/40791787 | PubMed |
| 40,567,403 | Micro-CT Analysis of Rodent Temporal Bones: Identifying Optimal Species for Otological Research. | Laryngoscope Investig Otolaryngol | 2025 | https://conductscience.org/library/papers/40567403 | PubMed |
| 40,251,388 | Cell tropism of adeno-associated viruses within the mouse inner ear in vivo: from embryonic to adult stages. | Sci Rep | 2025 | https://conductscience.org/library/papers/40251388 | PubMed |
| 39,655,096 | Efficiency of gene therapy for sensorineural hearing loss in mouse model: A meta-analysis. | Laryngoscope Investig Otolaryngol | 2024 | https://conductscience.org/library/papers/39655096 | PubMed |
| 39,641,274 | In vivo AAV9-Myo7a gene rescue restores hearing and cholinergic efferent innervation in inner hair cells. | JCI Insight | 2024 | https://conductscience.org/library/papers/39641274 | PubMed |
| 39,625,555 | Inner Ear Gene Therapy: An Overview from Bench to Bedside. | Mol Diagn Ther | 2025 | https://conductscience.org/library/papers/39625555 | PubMed |
1 to 10 of 17
See all 17 cited byGenes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KCNQ1 | 3,784 | PubTator's text mining | https://conductscience.org/library/genes/3784 | NCBI Gene |
| LHFPL5 | 222,662 | PubTator's text mining | https://conductscience.org/library/genes/222662 | NCBI Gene |
| OTOF | 9,381 | PubTator's text mining | https://conductscience.org/library/genes/9381 | NCBI Gene |
| PCDH15 | 65,217 | PubTator's text mining | https://conductscience.org/library/genes/65217 | NCBI Gene |
| PJVK | 494,513 | PubTator's text mining | https://conductscience.org/library/genes/494513 | NCBI Gene |
| STRC | 161,497 | PubTator's text mining | https://conductscience.org/library/genes/161497 | NCBI Gene |
| TMC1 | 117,531 | PubTator's text mining | https://conductscience.org/library/genes/117531 | NCBI Gene |
| USH1C | 10,083 | PubTator's text mining | https://conductscience.org/library/genes/10083 | NCBI Gene |
| WHRN | 25,861 | PubTator's text mining | https://conductscience.org/library/genes/25861 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36769694
GET https://conductscience.org/api/papers/v1/36769694/references?page=2